Oral iloprost in Raynaud's phenomenon secondary to systemic sclerosis: a multicentre, placebo-controlled, dose-comparison study

C. M. Black, L. Halkier-Sørensen, J. J. F. Belch, S. Ullman, R. Madhok, A. J. Smit, J.-D. Banga, H. R. Watson

    Research output: Contribution to journalArticlepeer-review

    113 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Oral iloprost in Raynaud's phenomenon secondary to systemic sclerosis: a multicentre, placebo-controlled, dose-comparison study'. Together they form a unique fingerprint.

    Keyphrases

    Medicine and Dentistry

    Pharmacology, Toxicology and Pharmaceutical Science

    Immunology and Microbiology